Pfizer Inc.

Stocks

PFE

US7170811035

Market Closed - NYSE Other stock markets 21:01:48 10/07/2026 BST			After hours 01:00:00
24.17 ^USD	-0.33%		24.20	+0.10%

07-10	Health Care Down on Rotation Back to Tech - Health Care Roundup	DJ
07-10	Merck, Pfizer, Astellas Bladder Cancer Treatment Approved by FDA	DJ

Transcript : Pfizer Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 08

Published on 06/08/2026 at 04:42 pm BST

S&P Capital IQ

Add MarketScreener to your sources

Presenter Speech
Asad Haider (Analysts)

Okay. Terrific. Good morning, everyone. Welcome to our 47th Annual Global Healthcare Conference here in sunny Miami. Hopefully, it stays that way. My name is

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Add MarketScreener to your sources

Latest news about Pfizer Inc.

07-10	Health Care Down on Rotation Back to Tech - Health Care Roundup	DJ
07-10	Merck, Pfizer, Astellas Bladder Cancer Treatment Approved by FDA	DJ
07-10	Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says	MT
07-10	Pfizer Poised for Mixed Second Quarter, RBC Says	MT
07-10	Pfizer Inc. and Astellas Pharma Inc. Receive U.S. FDA Approval for PADCEV Plus Keytruda as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer	CI
07-10	BofA Securities Adjusts Pfizer Price Target to $26 From $27	MT
07-10	PFIZER INC : RBC reiterates its Neutral rating	ZD
07-10	Pfizer Seen Reporting Q2 Revenue In Line With Consensus, EPS Below Estimates, RBC Says	MT
07-10	Polish air traffic control faces funding freeze over COVID vaccine ruling	RE
07-10	Pfizer's Vaccine Disputes With Poland, Romania Continue	MT
07-10	UK Stocks-Factors to watch on July 10	RE
07-10	US Appeals Court Upholds Ruling in Favor of AstraZeneca in Patent Case Against Pfizer Unit	MT
07-09	AstraZeneca Wins Pfizer Patent Battle Over Cancer Drug	MT
07-09	AstraZeneca Wins Pfizer Patent Battle Over Cancer Drug	MT
07-09	AstraZeneca's Wainua fails key heart disease trial, shares tumble	RE